Medications ›L1 protein, human papillomavirus type 52 vaccine

L1 protein, human papillomavirus type 52 vaccine

RxCUI 1596933 ingredient

Contraindicated with · 3

Diagnoses1

Condition families2

Indicated to prevent · 35

Diagnoses7

Carcinoma in Situ Genital Neoplasms, Female Sexually Transmitted Diseases, Viral Carcinoma Neoplasms, Glandular and Epithelial Genital Diseases, Female Disease Attributes

Condition families28

Anus Neoplasms Rectal Neoplasms Papillomavirus Infections Anus Diseases Tumor Virus Infections Colorectal Neoplasms Intestinal Neoplasms Rectal Diseases Gastrointestinal Neoplasms Digestive System Neoplasms DNA Virus Infections Sexually Transmitted Diseases Urogenital Neoplasms Communicable Diseases Virus Diseases Neoplasms by Histologic Type Genital Diseases Intestinal Diseases Neoplasms by Site Gastrointestinal Diseases Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Digestive System Diseases Urogenital Diseases Infections Pathologic Processes Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.